NIH unveils Dietary supplement label database
The Dietary Supplement Label Database provides the information related to the supplement facts panel that lists the dietary supplements’ contents and other added ingredients such as fillers, binders,
Anixa Biosciences has secured a patent from the Korean Ministry of Intellectual Property (MOIP) for its breast cancer vaccine technology.
Targeting Her2-positive breast cancer, ARX788 is developed by the clinical stage biopharmaceutical company Ambrx as site-specific ADC. According to the deal, both the companies will continue developing the